General Information
Revision date
2024-01-09
Product name
PLX259 PROLUXE WATER-BASED POLYURETHANE CLEAR SATIN INTERIOR / EXTERIOR CLEAR
1.2.1 Relevant identified uses
Consumer applications, Professional applications, Used by spraying
Manufacturer Name
PPG Industries, Inc
Emergency telephone
1-800-441-9695
Icons in SDS
Company Information
company name
PPG Industries, Inc
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361
Hazard statements
Code
Statements
H361
Suspected of damaging fertility or the unborn child
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
22.5% (oral), 22.5% (dermal), 32.3% (inhalation)
Signal word
Warning
Hazard statements
Suspected of damaging fertility or the unborn child.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves, protective clothing and eye or face protection.
Response
IF exposed or concerned: Get medical advice or attention.
Storage
Store locked up.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Repeated exposure to high vapor concentrations may cause irritation of the respiratory system and permanent brain and nervous system damage. Inhalation of vapor/aerosol concentrations above the recommended exposure limits causes headaches, drowsiness and nausea and may lead to unconsciousness or death. This product either contains formaldehyde or is capable of releasing formaldehyde above 0.5 ppm under certain conditions. Formaldehyde is a known cancer hazard, a skin sensitizer and a respiratory sensitizer. Avoid contact with skin and clothing. Wash thoroughly after handling. Emits toxic fumes when heated.
2.3 Other hazards
Prolonged or repeated contact may dry skin and cause irritation.
2.1 Classification of the substance or mixture
Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 22.5% (oral), 22.5% (dermal), 32.3% (inhalation)